Sign in
4

Changes in Ownership

Evofem Biosciences, Inc. Filed Acc 0001209191-15-013104

Options or other derivatives

  • Chief Financial Officer acquired 45,607 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Knudson Susan A. Chief Financial Officer 2015-02-10 Grant or award · Stock Option (Right to Buy) +45,607 45,607 D
Loading xslF345X03/doc4.xml…